Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA NEUROSURGERY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 INDUSTRIAL INSIGHTS:
4.4 CONCLUSION
5 REGULATIONS OF THE NORTH AMERICA NEUROSURGERY MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 TECHNOLOGICAL ADVANCEMENT IN NEUROSURGERY
6.1.2 RISING PREVALENCE OF NEUROLOGICAL CONDITIONS
6.1.3 DEVELOPMENTS IN SURGICAL EQUIPMENT
6.2 RESTRAINTS
6.2.1 THE HIGH COST ASSOCIATED WITH NEUROSURGERIES AND EQUIPMENT
6.2.2 UNFAVOURABLE REIMBURSEMENT POLICIES
6.3 OPPORTUNITIES
6.3.1 RISING AWARENESS ABOUT NEUROLOGICAL DISORDERS
6.3.2 INCREASING NUMBER OF KEY PLAYERS IN MARKET
6.3.3 ADVANCE PRODUCT DEVELOPMENT AND LAUNCHES IN RECENT YEARS
6.4 CHALLENGES
6.4.1 ALTERNATIVE TREATMENTS FOR NEUROLOGICAL DISEASE
6.4.2 STRINGENT REGULATIONS FOR APPROVAL OF MEDICAL DEVICES
7 NORTH AMERICA NEUROSURGERY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 NEUROSURGERY DEVICES
7.2.1 NEUROMODULATION DEVICES
7.2.1.1 INTERNAL NEUROMODULATION DEVICES
7.2.1.1.1 SPINAL CORD STIMULATION DEVICES
7.2.1.1.1.1 RECHARGEABLE
7.2.1.1.1.2 NON- RECHARGEABLE
7.2.1.1.2 DEEP BRAIN STIMULATION DEVICES
7.2.1.1.2.1 SINGLE-CHANNEL DEEP BRAIN STIMULATION
7.2.1.1.2.2 DUAL-CHANNEL DEEP BRAIN STIMULATION
7.2.1.1.3 SACRAL NERVE STIMULATION DEVICES
7.2.1.1.3.1 IMPLANTABLE
7.2.1.1.3.2 EXTERNAL
7.2.1.1.4 VAGUS NERVE STIMULATION DEVICES
7.2.1.1.4.1 INVASIVE
7.2.1.1.4.2 EXTERNAL
7.2.1.1.5 GASTRIC ELECTRICAL STIMULATION DEVICES
7.2.1.1.5.1 LOW FREQUENCY GASTRIC ELECTRICAL STIMULATORS
7.2.1.1.5.2 HIGH FREQUENCY GASTRIC ELECTRICAL STIMULATORS
7.2.1.1.6 EXTERNAL NEUROMODULATION DEVICES
7.2.1.1.6.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
7.2.1.1.6.2 TRANSCRANIAL MAGNETIC STIMULATION (TMS)
7.2.1.1.6.3 OTHERS
7.2.2 NEURO-INTERVENTIONAL DEVICES
7.2.2.1 EMBOLIZATION COILS
7.2.2.1.1 DETACHABLE
7.2.2.1.2 PUSHABLE
7.2.2.2 CAROTID STENTS
7.2.2.3 INTRACRANIAL STENTS
7.2.2.4 NEUROVASCULAR THROMBECTOMY
7.2.2.4.1 COIL RETRIEVERS
7.2.2.4.2 ASPIRATION DEVICES
7.2.2.4.3 STENT RETRIEVERS
7.2.2.5 INTRASSACULAR DEVICES
7.2.2.6 BALLOONS
7.2.2.7 OTHERS
7.2.3 NEUROSURGERY SURGICAL POWER TOOLS
7.2.3.1 DRILL
7.2.3.1.1 PNEUMATIC NEUROSURGICAL DRILLS
7.2.3.1.2 ELECTRICAL NEUROSURGICAL DRILLS
7.2.3.2 SAW
7.2.3.3 OTHERS
7.2.4 NEUROSURGICAL NAVIGATION SYSTEMS
7.2.5 CEREBROSPINAL FLUID (CSF) MANAGEMENT DEVICES
7.2.5.1 CSF SHUNTS
7.2.5.2 EXTERNAL DRAINAGE SYSTEM
7.2.6 NEUROSURGICAL MICROSCOPE
7.2.7 CRANIAL STABILIZATION
7.2.8 NEUROENDOSCOPY DEVICES
7.2.9 INTRA OPERATIVE IMAGING
7.2.10 BRAIN MONITORING
7.2.11 NEUROSURGICAL EVACUATION DEVICES
7.2.12 STEREOTACTIC SYSTEMS
7.2.13 ULTRASONIC ASPIRATOR
7.2.14 BIPOLAR EQUIPMENT
7.3 NEUROSURGERY SOFTWARE
7.3.1 IMAGING NEUROSURGERY SOFTWARE
7.3.2 PRE-OPERATION PLANNING NEUROSURGERY SOFTWARE
7.3.3 OTHERS
7.4 CONSUMABLES
8 NORTH AMERICA NEUROSURGERY MARKET, BY AGE GROUP
8.1 OVERVIEW
8.2 PEDIATRIC
8.3 ADULT
8.4 GERIATRIC
9 NORTH AMERICA NEUROSURGERY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BRAIN TUMORS
9.3 TRAUMA SURGERY
9.4 SPINE SURGERY
9.5 PARKINSON’S DISEASE AND TREMORS
9.6 PERIPHERAL NERVE SURGERY
9.7 EPILEPSY
9.8 FUNCTIONAL NEUROSURGERY
9.9 CAROTID ARTERY BLOCKAGE/STENOSIS
9.1 INTRAOPERATIVE ANGIOGRAPHY
9.11 CEREBROVASCULAR SURGERY
9.12 ANEURYSMS
9.13 PITUITARY TUMORS
9.14 RADIOSURGERY
9.15 STEREOTACTIC NEUROSURGERY
9.16 CORTICAL MAPPING
9.17 ARTERIOVENOUS MALFUNCTION (AVM)
9.18 SKULL BASE SURGERY
9.19 TRIGEMINAL NEURALGIA
9.2 OTHERS
10 NORTH AMERICA NEUROSURGERY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 ACUTE CARE HOSPITALS
10.2.2 LONG-TERM CARE HOSPITALS
10.2.3 NURSING FACILITIES
10.2.4 REHABILITATION CENTERS
10.3 RESEARCH CENTERS
10.4 NEUROSURGERY CENTERS
10.5 AMBULATORY SURGICAL CENTERS (ASCS)
10.6 OTHERS
11 NORTH AMERICA NEUROSURGERY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 NORTH AMERICA NEUROSURGERY MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA NEUROSURGERY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 MEDTRONIC
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 STRYKER
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ABBOTT
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 INTEGRA LIFESCIENCES (2021)
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ADEOR MEDICAL AG
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 ADVANTIS MEDICAL IMAGING
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 ALEVA NEUROTHERAPEUTICS
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 ANT NEURO
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 B. BRAUN SE
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 BIOINDUCTION
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 BRAINLAB AG
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 ELEKTA
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 EMS HANDELS GESELLSCHAFT MBH
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 INOMED MEDIZINTECHNIK GMBH
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 KARL STORZ SE & CO. KG
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 LEICA MICROSYSTEMS
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 LIVANOVA PLC
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 NEVRO CORP.
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 OPTOFINE INSTRUMENTS PVT. LTD.
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 PENUMBRA, INC.
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 RENISHAW PLC.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PORTFOLIO
15.22.4 RECENT DEVELOPMENT
15.23 SYNAPSE BIOMEDICAL INC.
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENT
15.24 TERUMO MEDICAL CORPORATION
15.24.1 COMPANY SNAPSHOT
15.24.2 REVENUE ANALYSIS
15.24.3 PRODUCT PORTFOLIO
15.24.4 RECENT DEVELOPMENTS
15.25 MACHIDA ENDOSCOPE CO., LTD.
15.25.1 COMPANY SNAPSHOT
15.25.2 PRODUCT PORTFOLIO
15.25.3 RECENT DEVELOPMENTS
15.26 NALU MEDICAL, INC.
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENT
15.27 WALLABY MEDICAL
15.27.1 COMPANY SNAPSHOT
15.27.2 PRODUCT PORTFOLIO
15.27.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 2 NORTH AMERICA NEUROSURGERY DEVICES IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA NEUROSURGERY DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA INTERNAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA SPINAL CORD STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA SACRAL NERVE STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA VAGUS NERVE STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA GASTRIC ELECTRICAL STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA EXTERNAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA NEURO-INTERVENTIONAL DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA EMBOLIZATION COILS IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA NEUROVASCULAR THROMBECTOMY IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA NEUROSURGICAL POWER TOOLS IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA DRILL IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA CEREBROSPINAL FLUID (CSF) MANAGEMENT DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA NEUROSURGERY SOFTWARE IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA NEUROSURGERY SOFTWARE IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA CONSUMABLES IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA NEUROSURGERY MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA PEDIATRIC IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA ADULT IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA GERIATRIC IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA NEUROSURGERY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA BRAIN TUMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA TRAUMA SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA SPINE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA PARKINSON’S DISEASE AND TREMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA PERIPHERAL NERVE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA EPILEPSY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA FUNCTIONAL NEUROSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA CAROTID ARTERY BLOCKAGE/STENOSIS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA INTERAOPERATIVE ANGIOGRAPHY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA CEREBROVASCULAR SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA ANEURYSMS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA PITUITARY TUMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA RADIOSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA STEREOTACTIC NEUROSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA CORTICAL MAPPING IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA ARTERIOVENOUS MALFUNCTION (AVM) IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA SKULL BASE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA TRIGEMINAL NEURALGIA IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA NEUROSURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA HOSPITALS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA HOSPITALS IN NEUROSURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA RESEARCH CENTERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA NEUROSURGERY CENTERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 50 NORTH AMERICA AMBULATORY SURGICAL CENTERS (ASCS) IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 NORTH AMERICA OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 52 NORTH AMERICA NEUROSURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 53 NORTH AMERICA DIRECT TENDER IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 54 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 55 NORTH AMERICA OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA NEUROSURGERY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA NEUROSURGERY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA NEUROSURGERY MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA NEUROSURGERY MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 NORTH AMERICA NEUROSURGERY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA NEUROSURGERY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA NEUROSURGERY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 NORTH AMERICA NEUROSURGERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA NEUROSURGERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA NEUROSURGERY MARKET: SEGMENTATION
FIGURE 11 THE GROWING PREVALENCE OF NEUROLOGICAL DISEASES, EFFORTS TO DEVELOP THE APPLICATION BASE FOR NEUROMODULATION, AND THE BENEFITS OF NEUROENDOSCOPIC SURGERIES OVER CONVENTIONAL BRAIN SURGERIES ARE EXPECTED TO DRIVE THE NORTH AMERICA NEUROSURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 NEUROSURGERY DEVICES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA NEUROSURGERY MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND, CHALLENGES OF NORTH AMERICA NEUROSURGERY MARKET
FIGURE 14 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE, 2021
FIGURE 15 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 16 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 17 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA NEUROSURGERY MARKET: BY AGE GROUP, 2021
FIGURE 19 NORTH AMERICA NEUROSURGERY MARKET: BY AGE GROUP, 2022-2029 (USD MILLION)
FIGURE 20 NORTH AMERICA NEUROSURGERY MARKET: BY AGE GROUP, CAGR (2022-2029)
FIGURE 21 NORTH AMERICA NEUROSURGERY MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 22 NORTH AMERICA NEUROSURGERY MARKET: BY APPLICATION, 2021
FIGURE 23 NORTH AMERICA NEUROSURGERY MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 24 NORTH AMERICA NEUROSURGERY MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 25 NORTH AMERICA NEUROSURGERY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA NEUROSURGERY MARKET: BY END USER, 2021
FIGURE 27 NORTH AMERICA NEUROSURGERY MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 28 NORTH AMERICA NEUROSURGERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 NORTH AMERICA NEUROSURGERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 31 NORTH AMERICA NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 32 NORTH AMERICA NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 33 NORTH AMERICA NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 NORTH AMERICA NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 35 NORTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021)
FIGURE 36 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT COUNTRY (2022 & 2029)
FIGURE 37 NORTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 38 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 39 NORTH AMERICA NEUROSURGERY MARKET: COMPANY SHARE 2021 (%)
